Literature DB >> 24092469

IL-1β strikingly enhances antigen-driven CD4 and CD8 T-cell responses.

S Z Ben-Sasson1, K Wang2, J Cohen2, W E Paul3.   

Abstract

Protective immune response requires massive expansion of antigen-triggered naïve cells, extensive differentiation into effector cells, migration of effectors into the periphery, and generation of a functional memory compartment. IL-1β strikingly enhances expansion of antigen-primed CD8 and CD4 T cells in vivo. Its T-cell expansion in lymph nodes and spleen was direct, requiring that the stimulated T cells express IL-1R1. Immunization in the presence of IL-1β increases the frequency of IL-17- and IFN-γ-producing cells among primed CD4 cells and the frequency of granzyme B-expressing and IFN-γ-producing cells and of cytotoxic cells among primed CD8 cells. IL-1β-induced increase in the number of the activated CD4 and CD8 cells and augmented differentiation of the antigen-triggered T cells is very pronounced in liver and lungs. CD4 and CD8 cells primed in the presence of IL-1β display augmented cell number and enhanced cytokine production when rechallenged 2 mo after priming with antigen and lipopolysaccharide (LPS). In five in vivo models, IL-1β enhanced the protective value of weak vaccines. Preliminary analysis of in vivo gene expression in CD4 cells stimulated with IL-1β revealed that IL-1β caused gene expression changes consistent with the up-regulation of pathways involved in cell replication, cell survival, and enhanced energy metabolism. Thus, IL-1β enhances antigen-primed CD4 and CD8 T-cell expansion, differentiation, and migration to the periphery and memory, the specific functions required for generation of effective protective immune responses.
Copyright © 2013 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24092469     DOI: 10.1101/sqb.2013.78.021246

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  30 in total

Review 1.  Inflammasomes and adaptive immune responses.

Authors:  Katherine A Deets; Russell E Vance
Journal:  Nat Immunol       Date:  2021-02-18       Impact factor: 25.606

2.  Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism.

Authors:  Crystal Morales Del Valle; Joseph R Maxwell; Maria M Xu; Antoine Menoret; Payal Mittal; Naomi Tsurutani; Adam J Adler; Anthony T Vella
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

3.  TLR4 ligands lipopolysaccharide and monophosphoryl lipid a differentially regulate effector and memory CD8+ T Cell differentiation.

Authors:  Weiguo Cui; Nikhil S Joshi; Ying Liu; Hailong Meng; Steven H Kleinstein; Susan M Kaech
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

4.  Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.

Authors:  Emilie Seydoux; Hong Liang; Natasha Dubois Cauwelaert; Michelle Archer; Nicholas D Rintala; Ryan Kramer; Darrick Carter; Christopher B Fox; Mark T Orr
Journal:  J Immunol       Date:  2018-05-16       Impact factor: 5.422

5.  Mesenchymal stem cell transplantation inhibited high salt-induced activation of the NLRP3 inflammasome in the renal medulla in Dahl S rats.

Authors:  Qing Zhu; Xiao-Xue Li; Weili Wang; Junping Hu; Pin-Lan Li; Sabena Conley; Ningjun Li
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-13

Review 6.  Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.

Authors:  Tin Kyaw; Karlheinz Peter; Yi Li; Peter Tipping; Ban-Hock Toh; Alex Bobik
Journal:  Br J Pharmacol       Date:  2017-06-13       Impact factor: 8.739

7.  Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin.

Authors:  Marlena M Westcott; Jason Smedberg; Matthew J Jorgensen; Shelby Puckett; Douglas S Lyles
Journal:  Vaccines (Basel)       Date:  2018-03-19

8.  Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis.

Authors:  Amy I Yu; Lili Zhao; Kathryn A Eaton; Sharon Ho; Jiachen Chen; Sara Poe; James Becker; Allison Gonzalez; Delaney McKinstry; Muneer Hasso; Jonny Mendoza-Castrejon; Joel Whitfield; Charles Koumpouras; Patrick D Schloss; Eric C Martens; Grace Y Chen
Journal:  Cell Rep       Date:  2020-04-07       Impact factor: 9.423

9.  FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity.

Authors:  Koshu Okubo; Pei X Liew; Vijayashree Mysore; Xavier Cullere; Joseph Mears; Florencia Rosetti; Fan Zhang; Iris Madera-Salcedo; Frank Rosenbauer; Richard M Stone; Jon C Aster; Ulrich H von Andrian; Andrew H Lichtman; Soumya Raychaudhuri; Tanya N Mayadas
Journal:  Nat Commun       Date:  2021-08-09       Impact factor: 14.919

10.  The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages.

Authors:  Houcine Bougherara; Fariba Némati; André Nicolas; Gérald Massonnet; Martine Pugnière; Charlotte Ngô; Marie-Aude Le Frère-Belda; Alexandra Leary; Jérôme Alexandre; Didier Meseure; Jean-Marc Barret; Isabelle Navarro-Teulon; André Pèlegrin; Sergio Roman-Roman; Jean-François Prost; Emmanuel Donnadieu; Didier Decaudin
Journal:  Oncotarget       Date:  2017-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.